Seegene (096530 KS): Recovery of Non-COVID Sales to Drive Future Growth
Seegene is seeing slow recovery in non-COVID product revenue, with Q2 non-COVID product revenue increasing 21% q/q. At the current level Seegene...
395 Views
Moderna (MRNA US): To Cash in on Omicron Fear
Moderna is set to fly high on the continuous increasing demand for its Covid vaccine and rich pipeline beyond Covid. Emerging Omicron variant is...
505 Views
Candela Medical IPO: InMode’s Competitor Filed To Go Public
Candela Medical, leading global aesthetic device company and one of the key competitors of InMode, plans to raise ~$250M at midpoint of the price...
377 Views
Seegene (096530 KS): Worst Seems to Be Over; Non-COVID Revenue to Dictate Long-Term Growth
Seegene is expected to see COVID testing revenue recovery in H2, driven by surging delta variants in Europe and some Asian countries. Non-COVID...
447 Views
Varian-Siemens Deal: DAX Promotion on the Cards for the Acquirer
This is the largest healthcare sector M&A Deal announced so far in 2020. Earlier this year, in March, Thermo Fisher Scientific Inc (TMO US)...
612 Views